General MedicationsORALStandard
ZURZUVAE
ZURANOLONE
Standard Dose
30MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ZURZUVAE is listed in Drugs@FDA under application 217369 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ZURANOLONE Form and strength CAPSULE;ORAL - 30MG Sponsor BIOGEN INC Submission history Latest submission status date: 2024-07-31 00:00:00.
Structured Monograph
Clinical summary
Approval overview ZURZUVAE is listed in Drugs@FDA under application 217369 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ZURANOLONE Form and strength CAPSULE;ORAL - 30MG Sponsor BIOGEN INC Submission history Latest submission status date: 2024-07-31 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.